Paper
Design, synthesis, and biological activity of a novel series of benzofuran derivatives against oestrogen receptor-dependent breast cancer cell lines.
Published Jan 7, 2020 · Li Jin, Q. Xie, E. Huang
Bioorganic chemistry
Q1 SJR score
13
Citations
0
Influential Citations
Abstract
Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
In Vitro StudyStudy Snapshot
The novel benzofuran scaffold shows promising potential for developing potential oestrogen receptor inhibitors, with excellent activity against estrogen receptor-dependent breast cancer cells and low toxicity.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.
Sign up to use Study Snapshot
Consensus is limited without an account. Create an account or sign in to get more searches and use the Study Snapshot.
Full text analysis coming soon...
References
Changes in Biomarker Status in Metastatic Breast Cancer and Their Prognostic Value
Changes in biomarker status are common in metastatic breast cancer, with negative conversion of estrogen receptor status being a predictor of poor prognosis.
2019·25citations·J. Woo et al.·Journal of Breast Cancer
Journal of Breast Cancer
New quinoline/chalcone hybrids as anti-cancer agents: Design, synthesis, and evaluations of cytotoxicity and PI3K inhibitory activity.
Quinline-chalcone hybrids show promising anti-cancer activity against NSCLC and CML by inhibiting the PI3K/Akt/mTOR pathway.
2019·46citations·S. Abbas et al.·Bioorganic chemistry
Bioorganic chemistry
A Novel Strategy to Improve Women’s Health: Selective Estrogen Receptor Modulators
Selective estrogen receptor modulators (SERMs) can prevent osteoporosis and breast cancer while maintaining a healthy weight, with five FDA-approved options available.
2018·6citations·B. Abderrahman et al.·Estrogen Receptor and Breast Cancer
Estrogen Receptor and Breast Cancer
Design, synthesis and evaluation of novel sophoridinic imine derivatives containing conjugated planar structure as potent anticancer agents.
Novel sophoridine imine derivatives with conjugated planar structure show potent anticancer activity, particularly against HepG-2 and HeLa cell lines, suggesting potential as novel Topo I inhibitors.
2018·14citations·Yiming Xu et al.·Bioorganic & medicinal chemistry
Bioorganic & medicinal chemistry
Long-Term Treatment of Tamoxifen and Raloxifene Alleviates Dystrophic Phenotype and Enhances Muscle Functions of FKRP Dystroglycanopathy.
Tamoxifen and raloxifene show significant potential in treating FKRP-related muscular dystrophy, with potential for use in both male and female patient populations.
2018·27citations·B. Wu et al.·The American journal of pathology
The American journal of pathology
Citations
Detection of isoflavones and phytoestrogen-rich plant extracts binding to estrogen receptor β using a yeast-based fluorescent assay.
This study developed a yeast-based fluorescent assay to identify phytoestrogen-rich plant extracts binding to estrogen receptor, aiding in the assessment of their estrogenic potential and potential treatment of estrogen-related disorders.
2024·0citations·Sofija S Bekić et al.·Analytical biochemistry
Analytical biochemistry
New Derivatives of 1-(3-Methyl-1-Benzofuran-2-yl)Ethan-1-one: Synthesis and Preliminary Studies of Biological Activity
Two new derivatives of 1-(3-Methyl-1-Benzofuran-2-yl)Ethan-1-one show selective action against K562 cancer cells and exhibit proapoptotic properties, with compound 7 showing moderate antimicrobial activity against Gram-positive strains.
2024·3citations·M. Napiórkowska et al.·International Journal of Molecular Sciences
International Journal of Molecular Sciences
Anticancer therapeutic potential of benzofuran scaffolds
Benzofuran scaffolds show promising anticancer potential due to their exceptional inhibitory potency against a panel of human cancer cells compared to reference drugs.
2023·14citations·A. A. Abbas et al.·RSC Advances
RSC Advances
Aminobenzofuran-containing analogues of proximicins exhibit higher antiproliferative activity against human UG-87 glioblastoma cells compared to temozolomide
Aminobenzofuran-containing proximicin analogues show higher antiproliferative activity against human glioblastoma cells compared to temozolomide, offering potential as a new treatment option for glioblastoma.
2023·0citations·Nasrin Shokrzadeh Madieh et al.·RSC Advances
RSC Advances
Design, synthesis and biological activity against estrogen receptor-dependent breast cancer of furo[1]benzofuran derivatives
Furo[1]benzofuran derivatives show promising anti-estrogen receptor-dependent breast cancer activities with weak toxicity to healthy cells.
2022·2citations·Li Jin et al.·Arabian Journal of Chemistry
Arabian Journal of Chemistry
Recent Advancements in the Development of Anti-Breast Cancer Synthetic Small Molecules
Synthetic compounds with promising anti-breast cancer activity are being developed, offering a promising alternative to current treatments and addressing multidrug resistance and side effects.
2021·11citations·E. Elkaeed et al.·Molecules
Molecules
Synthesis and structure-activity relationships of hydroxylated and halogenated 2,4-diaryl benzofuro[3,2-b]pyridin-7-ols as selective topoisomerase IIα inhibitors.
Hydroxylated and halogenated 2,4-diaryl benzofuro[3,2-b]pyridin-7-ols show potential as selective topoisomerase II inhibitors and show selectivity towards T47D human cancer cells.
2021·4citations·Til Bahadur Thapa Magar et al.·Bioorganic chemistry
Bioorganic chemistry